23-HEM-20-SA (EFC17757): A Randomized, Double-blind, Multicenter,Phase 3 Study to Evaluate Efficacy and Safety of Belumosudil in Combination With Corticosteroids Versus Placebo in Combination with Corticosteroids in Participants at Least 12 Years of Age W

Grants and Contracts Details

StatusActive
Effective start/end date4/1/244/1/26

Funding

  • Sanofi Aventis US Inc: $2.00